Phase II Trial of NY-ESO-1 Targeted T Cells in Oesophagogastric Cancer

• Research type

  Research Study

• Full title

  A Phase II Trial to Assess the Activity of NY-ESO-1 Targeted T Cells in Advanced Oesophagogastric Cancer

• IRAS ID

  122513

• Contact name

  Fiona Claire Thistlewaite

• Contact email

  fiona.thistlewaite@christie.nhs.uk

• Sponsor organisation

  The Christie NHS Foundation Trust

• Eudract number

  2012-005327-33

• Clinicaltrials.gov Identifier

  NCT01795976

• REC name

  Scotland A REC

• REC reference

  13/SS/0041

• Date of REC Opinion

  26 Mar 2013

• REC opinion

  Favourable Opinion